PJSC Pharmaceutical Plant EGIS

Ukraine

All drugs from this manufacturer

  • SETEGIS

    The drug is used for the symptomatic treatment of urinary retention in benign prostatic hyperplasia, as well as for the treatment of arterial hypertension (high blood pressure).

    Dosage form: tablets

    Active substance Dosage
    terazosin 5 mg

    ATC: G04CA03

  • The drug is used for the symptomatic treatment of urinary retention in benign prostatic hyperplasia, as well as for the therapy of arterial hypertension (high blood pressure).

    Dosage form: tablets

    Active substance Dosage
    terazosin 10 mg

    ATC: G04CA03

  • The drug is used for the prevention and treatment of iron deficiency anemia.

    Dosage form: tablets, coated, modified release

    Active substance Dosage
    iron 100 mg
    ascorbic acid 60 mg

    ATC: B03AE10

  • The drug is used for the treatment (and prevention) of major depressive episodes, panic disorders, obsessive-compulsive disorder (OCD) in adults and children from 6 years of age, social anxiety disorder, and post-traumatic stress disorder (PTSD).

    Dosage form: tablets, film-coated

    Active substance Dosage
    sertraline 100 mg

    ATC: N06AB06

  • The drug is used for the treatment of major depressive episodes (and the prevention of their recurrence), panic disorders, obsessive-compulsive disorder (OCD) in adults and children (from 6 years old), social anxiety disorder, and post-traumatic stress disorder (PTSD).

    Dosage form: tablets, film-coated

    Active substance Dosage
    sertraline 50 mg

    ATC: N06AB06

  • The drug is used to treat infections caused by susceptible microorganisms. Specifically, it is used for respiratory tract infections (bronchitis, pneumonia, pharyngitis, sinusitis), urinary tract infections (cystitis, pyelonephritis, prostatitis), gastrointestinal tract infections (typhoid fever, cholera, traveler's diarrhea), as well as brucellosis, nocardiosis, toxoplasmosis, and other bacterial infections.

    Dosage form: tablets

    Active substance Dosage
    sulfamethoxazole 400 mg
    trimethoprim 80 mg

    ATC: J01EE01

  • The drug is used for seasonal allergic rhinitis, conjunctivitis, urticaria, contact dermatitis, food allergies, insect bites, or drug allergies. It is also used as an adjunct therapy in severe allergic reactions (anaphylactic shock) and edema.

    Dosage form: solution for injection

    Active substance Dosage
    chloropyramine 20 mg/ml

    ATC: R06AC03

  • The drug is used to treat allergic diseases, such as seasonal allergic rhinitis, conjunctivitis, urticaria, contact dermatitis, allergies to insect bites or medications, as well as for itching. It is also used as adjunctive therapy for edema and systemic anaphylactic reactions.

    Dosage form: tablets

    Active substance Dosage
    chloropyramine 25 mg

    ATC: R06AC03

  • The drug is used to treat acute psychotic states accompanied by agitation and severe anxiety (e.g., acute episodes of schizophrenia), as well as for adjunctive therapy in chronic psychoses.

    Dosage form: tablets, film-coated

    Active substance Dosage
    levomepromazine 25 mg

    ATC: N05AA02

  • The drug is used for the treatment of acute psychotic states accompanied by agitation and severe anxiety (e.g., schizophrenia attacks), as well as for adjunctive treatment in chronic psychoses.

    Dosage form: solution for injection

    Active substance Dosage
    levomepromazine 25 mg/ml

    ATC: N05AA02

  • The drug is used for the treatment and prevention of major depressive episodes, as well as for the treatment of generalized anxiety disorder and social phobia.

    Dosage form: capsules, extended-release

    Active substance Dosage
    venlafaxine 37.5 mg

    ATC: N06AX16

  • The drug is used for the treatment and prevention of major depressive episodes, as well as for the treatment of generalized anxiety disorder and social phobia.

    Dosage form: capsules, extended-release

    Active substance Dosage
    venlafaxine 75 mg

    ATC: N06AX16

  • The drug is used for the treatment and prevention of major depressive episodes, as well as for the treatment of generalized anxiety disorder and social phobia.

    Dosage form: capsules, extended-release

    Active substance Dosage
    venlafaxine 150 mg

    ATC: N06AX16